Chemotherapy Cost in India for Foreign Patients: Full Breakdown 2026

Chemotherapy Cost in India for Foreign Patients: Full Breakdown 2026 — medical tourism India

Cancer treatment in India costs 70–85% less than in the United States or United Kingdom, with standard chemotherapy cycles starting from $300 per session. For international patients facing a cancer diagnosis, India's oncology infrastructure — anchored by institutions like Tata Memorial Hospital in Mumbai, Apollo Cancer Institute, and Max Cancer Centre in Delhi — offers world-class treatment at a fraction of Western prices, without compromise in drug quality or clinical expertise.

This guide gives you a transparent, protocol-by-protocol cost breakdown so you can budget realistically before making any decisions.

TL;DR: Standard IV chemotherapy in India costs $300–$800 per cycle versus $5,000–$15,000 in the USA for the same drugs. A full 6-cycle course runs $2,000–$6,000 for standard solid tumour regimens. Targeted therapy and immunotherapy are significantly higher but still 65–80% cheaper than US pricing. All leading Indian cancer centres use the same generic drugs supplied to the US FDA market.

What Does Chemotherapy Actually Cost Per Cycle in India?

Standard IV chemotherapy protocols in India range from $300 to $800 per cycle at quality NABH-accredited hospitals, based on 2026 data from leading oncology centres (Arodya partner hospital consultations, 2026). The total per-cycle cost includes the chemotherapy drug itself, intravenous administration, pre-medication (anti-emetics, steroids), nursing supervision, and same-day discharge. Targeted therapy agents like trastuzumab (Herceptin) or rituximab cost more per cycle due to drug manufacturing complexity — but still represent 65–75% savings over US pricing.

The single most important driver of cost is drug choice. A carboplatin/paclitaxel cycle costs under $500; a pembrolizumab (Keytruda) immunotherapy cycle costs $1,500–$4,000 in India versus $15,000–$25,000 in the USA.

Arodya Data

Based on Arodya's coordination of cancer treatment cases for international patients in 2025–2026, the most common pattern is for patients to initiate their first 1–2 cycles in India for hospital assessment, drug tolerance evaluation, and treatment protocol confirmation — then continue the same protocol with their local oncologist at home using India's detailed treatment plan.

Cost Breakdown by Drug Protocol Type

India's cost advantage varies significantly depending on the chemotherapy regimen. Here is a protocol-by-protocol breakdown:

Standard Platinum-Based Regimens

Used for: lung cancer, ovarian cancer, head and neck cancer, bladder cancer

Protocol Drugs Cost Per Cycle (India) Cost Per Cycle (USA)
Carboplatin + Paclitaxel Carboplatin, Paclitaxel $350–$600 $5,000–$8,000
Cisplatin + Gemcitabine Cisplatin, Gemcitabine $300–$550 $4,500–$7,000
FOLFOX (colorectal) Oxaliplatin, Leucovorin, 5-FU $400–$700 $5,500–$9,000
FOLFIRI (colorectal) Irinotecan, Leucovorin, 5-FU $350–$600 $4,800–$7,500

Anthracycline-Based Regimens

Used for: breast cancer, lymphoma, leukaemia

Protocol Drugs Cost Per Cycle (India) Cost Per Cycle (USA)
AC (breast cancer) Doxorubicin, Cyclophosphamide $300–$500 $4,000–$7,000
R-CHOP (lymphoma) Rituximab + CHOP agents $900–$1,800 $8,000–$18,000
EC (breast cancer) Epirubicin, Cyclophosphamide $350–$550 $4,500–$7,500

Targeted Therapy

Used for: HER2+ breast cancer, chronic myeloid leukaemia, EGFR-mutant lung cancer

Drug Indication Cost Per Cycle (India) Cost Per Cycle (USA)
Trastuzumab (Herceptin) HER2+ breast cancer $800–$1,800 $8,000–$15,000
Imatinib (Gleevec) CML (oral, monthly) $400–$700 $8,000–$12,000
Erlotinib / Gefitinib EGFR-mutant lung (oral) $350–$600 $6,000–$9,000
Bevacizumab (Avastin) Colorectal, lung, ovarian $1,200–$2,500 $10,000–$20,000

Immunotherapy

Used for: melanoma, lung cancer, bladder cancer, head and neck cancer

Drug Indication Cost Per Cycle (India) Cost Per Cycle (USA)
Pembrolizumab (Keytruda) Multiple solid tumours $1,500–$3,500 $15,000–$25,000
Nivolumab (Opdivo) Lung, melanoma, renal $1,400–$3,200 $13,000–$22,000
Atezolizumab (Tecentriq) Lung, bladder $1,300–$3,000 $12,000–$20,000

Total Treatment Cost: A Realistic Full-Course Budget

Most solid tumour chemotherapy protocols involve 6–8 cycles spaced 3 weeks apart, making a complete course run 18–24 weeks. Here is a realistic total treatment budget for common cancer types:

Cancer Type Protocol Cycles Total Cost India Total Cost USA
Breast cancer (early stage) AC → Paclitaxel 8 $3,500–$6,500 $40,000–$80,000
Colorectal cancer FOLFOX 12 $5,000–$9,000 $65,000–$110,000
Lung cancer (standard chemo) Carboplatin + Paclitaxel 6 $2,500–$4,500 $30,000–$55,000
Lymphoma R-CHOP 6 $6,000–$12,000 $55,000–$115,000
HER2+ breast cancer Trastuzumab maintenance 18 $14,000–$32,000 $130,000–$250,000
Lung cancer (immunotherapy) Pembrolizumab 8 $12,000–$28,000 $120,000–$200,000

Which Hospitals in India Offer Chemotherapy for International Patients?

Not all oncology centres are equal. India's best cancer hospitals for international patients combine high chemotherapy volumes, sub-specialist oncologists (medical, surgical, radiation), and dedicated international patient infrastructure.

Tata Memorial Hospital, Mumbai

India's most celebrated cancer centre, Tata Memorial is a government-funded institution with one of the world's highest oncology patient volumes. It is associated with the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) for complex cases. International patients are seen at the Homi Bhabha Cancer Hospital network. Cost point: among the most affordable, though administrative processes may be slower than private hospitals.

Apollo Cancer Institute

Apollo operates cancer institutes across Delhi, Chennai, Hyderabad, and Kolkata. The Chennai campus is particularly strong in oncology. Apollo's international patient department handles everything from visa letters to care coordination. Cost point: mid-to-upper range among private centres.

Max Cancer Centre, Saket (Delhi)

Max Super Speciality Hospital's cancer centre is one of Delhi's strongest for medical oncology and haematology. Strong bone marrow transplant programme. Good international patient infrastructure. Cost point: 15–20% below Apollo for comparable protocols, making it strong value for cancer cases.

Medanta Cancer Institute, Gurugram

Part of the broader Medanta Medicity campus, the cancer institute benefits from multi-disciplinary tumour boards with specialists from cardiac, neuro, and gastrointestinal surgery all available for complex cases. Cost point: comparable to Apollo.

HCG Cancer Centre, Bangalore

HCG (Healthcare Global Enterprises) is India's largest specialist cancer network with 21 centres. Their Bangalore flagship is highly regarded for radiation oncology and bone marrow transplants. Cost point: mid-range, often 10–15% below Delhi pricing.

KIMS Hospital, Hyderabad

KIMS offers competitive oncology pricing in Hyderabad's PPP-adjacent hospital ecosystem. Strong for solid tumour chemotherapy. Cost point: typically 20–25% below Delhi pricing for standard protocols.

For a deeper look at why Hyderabad's PPP hospital structure keeps oncology costs lower, read our guide to India's public-private partnership medical hubs.

City-Wise Cost Comparison for Cancer Treatment

Chemotherapy costs vary meaningfully across Indian cities. Here is a representative comparison for a standard carboplatin/paclitaxel cycle (all costs in USD):

City Cost Per Cycle Strongest Cancer Centres
Mumbai $350–$700 Tata Memorial, Kokilaben, Nanavati Max
Delhi-NCR $400–$800 Max, Apollo, Medanta, Fortis
Chennai $300–$650 Apollo Cancer Institute, Cancer Institute WIA
Hyderabad $280–$600 KIMS, Yashoda, Apollo Hyderabad
Bangalore $300–$650 HCG, Narayana Health, Manipal

Mumbai and Delhi carry slightly higher prices due to operating costs, but host India's most experienced oncology sub-specialists. Chennai and Hyderabad offer the most competitive pricing for standard protocols.

How India's Pharmaceutical Industry Keeps Drug Costs Low

Arodya Insight

India's cost advantage in chemotherapy is not about lower-quality drugs — it is about manufacturing economics. India is the world's largest supplier of generic pharmaceuticals, supplying drugs to the US FDA, European EMA, and WHO prequalification programmes. Companies like Cipla, Sun Pharma, Dr. Reddy's Laboratories, and Hetero manufacture generic versions of oncology drugs — including carboplatin, paclitaxel, bevacizumab biosimilars, and trastuzumab biosimilars — at 60–80% below the cost of branded originals, while meeting the same bioequivalence standards.

When an Indian oncologist prescribes "Herclon" (Cipla's trastuzumab) rather than branded Herceptin, the drug mechanism, efficacy, and safety profile are identical — only the manufacturing cost and margin differ. International patients receive the same molecules that would be used in their home country, at a fraction of the price.

Beyond the Drug: Additional Cost Components

International patients must budget for costs beyond the chemotherapy drug itself:

Component Cost Per Cycle (USD)
Administration fee (IV setup, nursing) $50–$120
Pre-medication (anti-emetics, steroids) $20–$60
Pre-chemotherapy blood panel $30–$80
Oncologist consultation per visit $30–$100
Full staging PET-CT scan (if needed) $250–$500
Chemotherapy port placement (one-time) $200–$400
Same-day discharge or short stay Included in most packages

For patients requiring hospitalisation during chemotherapy (for high-dose regimens or complications), add $60–$150 per night for a private room.

Accommodation and Living Costs Between Cycles

For international patients completing multiple cycles in India, factor in accommodation between cycles:

Accommodation Type Nightly Cost (USD) Monthly Total (USD)
Hospital guest house $20–$40 $600–$1,200
Service apartment near hospital $35–$70 $1,050–$2,100
Mid-range hotel $40–$80 $1,200–$2,400

Most international patients stay 3–4 weeks in India for initial assessment and first 1–2 cycles, then return for subsequent cycles or transfer the protocol to their local oncologist.

Practical Steps for International Patients Seeking Chemotherapy in India

1. Share your pathology and imaging reports remotely.
Send your biopsy report, PET-CT or CT scan, and any previous treatment summary to the oncology department's international patient desk. Most major cancer centres respond within 48–72 hours with a preliminary treatment recommendation and cost estimate.

2. Get a written treatment plan before booking flights.
Ask the oncologist for a written protocol specifying the drug regimen, number of cycles, cycle spacing, and monitoring requirements. This allows your local oncologist at home to review and coordinate.

3. Apply for a Medical Visa (M-Visa).
Your hospital's international patient department will issue an invitation letter. Processing typically takes 5–10 business days. Companions travel on a Medical Attendant Visa (MX-Visa).

4. Plan for 3–4 weeks for initial assessment and first cycles.
Arrive 2–3 days before your first cycle for baseline bloodwork, staging confirmation, and oncology consultation. Stay through your first 1–2 cycles to ensure drug tolerance before flying home.

5. Arrange telemedicine follow-up for ongoing cycles.
Major Indian cancer centres offer video consultations for cycle monitoring, enabling international patients to continue their protocol with their local oncologist while staying in contact with the Indian specialist.

For more on the medical tourism landscape and what drives India's cost advantage, see our medical tourism growth statistics for India 2026.


Share this article

Frequently Asked Questions

Ready to explore treatment options in India?

Get a free case review from our coordinators within 24 hours. No commitment required.